Epidemiology of polymyalgia rheumatica in Olmsted County, Minnesota, 1970-1991.
about
Statin-associated polymyalgia rheumatica. An analysis using WHO global individual case safety database: a case/non-case approachGiant cell arteritis: a review.Diagnostic performance of ¹⁸F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a systematic review and meta-analysis.Polymyalgia rheumatica and giant cell arteritis in older patients: diagnosis and pharmacological management.Association of polymyalgia rheumatica with socioeconomic status in primary care: a cross-sectional observational study.Musculoskeletal manifestations in a population-based cohort of patients with giant cell arteritis.Inflammatory rheumatologic disorders in the elderly. Unusual presentations, altered outlooks.Autoimmunity and geriatrics: clinical significance of autoimmune manifestations in the elderly.Genetic and environmental factors in polymyalgia rheumatica.The rate of polymyalgia rheumatica (PMR) and remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome in a clinic where primary care physicians are working in JapanThe prevalence of giant cell arteritis and polymyalgia rheumatica in a UK primary care population.The Rochester Epidemiology Project: exploiting the capabilities for population-based research in rheumatic diseases.Epidemiology of autoimmune diseases in DenmarkGiant cell arteritis (temporal arteritis): A report of four cases from north east India.Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseasesAdvances and challenges in the diagnosis and treatment of polymyalgia rheumatica.Medical management of polymyalgia rheumatica.Current understanding and management of giant cell arteritis and polymyalgia rheumatica.Immunotherapeutic implication of IL-6 blockade.Recent advances in polymyalgia rheumatica.The Role of 18F Fluorodeoxyglucose Positron Emission Tomography Scanning in the Diagnosis and Management of Systemic Vasculitis.Giant Cell Arteritis: Beyond Corticosteroids.Recent advances in the diagnosis and treatment of polymyalgia rheumatica.Epidemiology of Polymyalgia Rheumatica 2000-2014 and Examination of Incidence and Survival Trends Over 45 Years: A Population-Based Study.Treatment of giant-cell arteritis, a literature review.Diagnosis of polymyalgia rheumatica usually means a favourable outcome for your patient.Prevalence of long-term oral glucocorticoid prescriptions in the UK over the past 20 years.Remediable hyperglycaemia in a patient with polymyalgia rheumatica.What happens to new-onset headache presented to primary care? A case-cohort study using electronic primary care records.Assessment of 2012 EULAR/ACR new classification criteria for polymyalgia rheumatica in Japanese patients diagnosed using Bird's criteria.Vascular endothelial growth factor production in polymyalgia rheumatica
P2860
Q28481469-ED7AF092-3AB9-4A0D-AD3A-F64728C19788Q33688189-A56576B4-D11A-4E2C-AD03-DA131E069B89Q33895383-138B9BB7-7FB4-491C-A87A-CC9A34822D24Q34205665-47C31FC5-4938-4FCC-A015-C973937A5C54Q34228360-4700952D-D1CF-434F-A90B-49FECAF46B2DQ34503842-D91F7D97-9E45-40FC-86D6-4D5F07AC4B9FQ34621095-5F8EDF5C-2272-4398-A6BD-495039F97EB9Q35135284-9853E9A5-445C-42C7-8D27-EAFF87BFBDA8Q35546924-96DBC5DE-6514-461A-A91F-F64AB93CEF8DQ35999161-97F23ED2-EA1F-41D8-87E2-7FBCFBBE3FD4Q36078820-1C4E96E9-695A-404D-A712-F2A614A5B156Q37027093-D9ADEE4D-F7CA-4666-8721-738DDBBC1E5BQ37278627-CAF555C3-4E10-4192-80B1-2CCD59ACD093Q37409061-05D8EB30-1F49-49CD-8E33-8FC38CCDF4B1Q37438934-B587EE72-FDDE-47E0-B26A-143BF7BE7A2EQ37498527-1ADAE169-0EFB-480B-BF47-E70FC6FF61C5Q37724384-743A27FC-2CD4-48AD-B7B3-68D6472FF256Q37803414-88ED67E3-90C9-4A6C-8B61-929D761049C2Q37965754-FD50BC26-25C0-40FB-B30E-702A362BFC84Q38513257-0EA30B00-8495-4C1E-A627-F03CE00B0691Q38547761-B10B8F64-4353-4995-A6C5-0AC52849FB1EQ38560322-D4A51C8C-56AD-4606-BA8B-871DA0B79BE2Q38808560-74A7F6FC-F514-416A-BF85-84D3180D67B1Q38987542-6D4CFEE9-6F59-4B1A-8FAF-24A24FD16325Q39029638-659E0E97-5A82-4ABD-A4F8-0D5B5673A69EQ42689593-9DA9835D-BB93-4CCE-B6FF-E9972B4B456AQ46747559-C316F8BE-C3AD-4A2D-AA12-5F336670E506Q46879922-5D31B7F8-BD6E-4392-95F5-50C24D6E512CQ48939295-F105671C-E915-410F-A05F-CEEB136C92E0Q51109445-83EF0AC6-0274-4D67-8A03-77488B3DCA68Q57009056-DC4F1A27-E0B0-4706-9F5B-ADE79999E91C
P2860
Epidemiology of polymyalgia rheumatica in Olmsted County, Minnesota, 1970-1991.
description
1995 nî lūn-bûn
@nan
1995 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի մարտին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Epidemiology of polymyalgia rheumatica in Olmsted County, Minnesota, 1970-1991.
@ast
Epidemiology of polymyalgia rheumatica in Olmsted County, Minnesota, 1970-1991.
@en
Epidemiology of polymyalgia rheumatica in Olmsted County, Minnesota, 1970-1991.
@nl
type
label
Epidemiology of polymyalgia rheumatica in Olmsted County, Minnesota, 1970-1991.
@ast
Epidemiology of polymyalgia rheumatica in Olmsted County, Minnesota, 1970-1991.
@en
Epidemiology of polymyalgia rheumatica in Olmsted County, Minnesota, 1970-1991.
@nl
prefLabel
Epidemiology of polymyalgia rheumatica in Olmsted County, Minnesota, 1970-1991.
@ast
Epidemiology of polymyalgia rheumatica in Olmsted County, Minnesota, 1970-1991.
@en
Epidemiology of polymyalgia rheumatica in Olmsted County, Minnesota, 1970-1991.
@nl
P2093
P356
P1476
Epidemiology of polymyalgia rheumatica in Olmsted County, Minnesota, 1970-1991.
@en
P2093
Gabriel SE
O'Fallon WM
Salvarani C
P304
P356
10.1002/ART.1780380311
P577
1995-03-01T00:00:00Z